Axogen, Inc. (AXGN) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Axogen, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Electromedical & Electrotherapeutic Apparatus
High 45.85 at 4:15 am ET, low 44.24 at 3:45 pm ET.
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
the bull case· 4
254
managers reporting a position in thirteen f filings
13fJun 30 '26+5.54%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '263
disclosed supplier and customer ties in sec filings
sec filingsedgar43
managers whose positions together make up four fifths of the reported value
13fJun 30 '26the bear case· 4
3
of the funds on file reporting a position in AXGN
n-portas of Jun 30 '260.08%
of iShares Russell two thousand etf's assets the largest fund weight on file
n-portJun 30 '268 of 23
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '265 of 7
recent reports where the move came in under the options implied range
earnings historyimplied vs realizedSides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 4 '26 report. Not a forecast, not advice.
Of the 6 companies Axogen, Inc. moves with most closely, none share its SEC classification.
Measured against 147 trading days of our own closes. Co-movement, not cause.
SIC 3845, Electromedical & Electrotherapeutic Apparatus, from each company's own filings. Largest first.
254 managers report a position worth $2.4B between them, and 43 of them hold 80% of it.
tall tick = annual report · 1 on record
AXGN (Axogen, Inc.) has 3 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.